Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.


Decentralized clinical trials (DCTs) are here to stay. Hybrid solutions that bring trials to the patient are the new, faster, and more patient friendly norm. IQVIA Decentralized Trials deliver purpose-built clinical and technology solutions that engage the right patients
wherever they are. Our hybrid and fully virtual models have been fine-tuned through more than 90 decentralized clinical trials (DCTs) across 30 therapy areas and 40+ countries.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.